Reuters logo
9 天前
BRIEF-Merrimack reports Q2 loss per share $0.22
2017年8月9日 / 上午11点09分 / 9 天前

BRIEF-Merrimack reports Q2 loss per share $0.22

Aug 9 (Reuters) - Merrimack Pharmaceuticals Inc

* Merrimack reports second quarter 2017 financial results

* Q2 loss per share $0.22

* Merrimack - continues to believe cash, cash equivalents as of june 30, potential milestone payments, to be sufficient to fund operations into H2 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below